Top Section/Ad
Top Section/Ad
Most recent
The widely expected sell-down in the National Bank of Greece came at a 1.31% discount
BNP Paribas took Pirelli and Citi took Renk as shareholders exited and trimmed stakes on Tuesday night
Rump placement was 814% oversubscribed, Almarai shares to be distributed
Investors commit to French capital raise despite moribund market
More articles/Ad
More articles/Ad
More articles
-
TP ICAP, the interdealer broker, received strong demand from its shareholders for its £315m rights issue to part-fund the acquisition of Liquidnet. -
Mitchell & Butlers, a company that owns UK pubs and restaurant chains including Harvester, will raise £350m through an underwritten equity raise to navigate its way through the latest Covid-19 lockdown. A shareholder consortium made up of Joe Lewis (the owner of Tottenham Hotspur); former Manchester United owners JP McManus and John Magnier; and currency trader Derrick Smith, will back the raise.
-
London’s investment trusts have been tapping a deep pool of equity capital earmarked for green-linked deals. On Friday, SDCL Energy Efficiency Income Trust (SEEIT), the UK-listed energy efficiency investor, closed a £160m raise, £60m more than its original target and on the same day Greencoat UK Wind, the investment trust focused on UK wind farms, launched a £197.6m follow-on.
-
Renewable energy companies have rushed to the European equity capital markets in 2021 to issue about $2.3bn of paper, according to Dealogic data. The figure is by far the best ever start to a year for green equity issuance, and with investor demand for paper increasing, sources predict there will be much more supply to meet it.
-
Nordic Entertainment Group (NENT), a Swedish entertainment company that operates video streaming and television services, completed a Skr4.35bn ($523m) capital raise on Wednesday evening and attracted enough investor demand to price a larger deal than originally intended.
-
UK biotech firms are continuing to reap the benefits from US listings. On Tuesday Autolus Therapeutics, an early stage biopharma firm backed by Syncona Investments, became the latest UK Biotech firm to raise capital on the US Nasdaq in a $100m transaction. The deal shows the continued advantages for early stage European biotech firms in having a US listing.
